Patent · US Active

Plasmid encoding human BMP-7

US7771995B2 · kind B2 · utility

0Cited by
2References
9Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 16, 2007
Grant dateAug 10, 2010
Priority date
Expiry dateDec 14, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/107
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of both acute and chronic renal failure in mammals, advantageously in humans, dogs and cats, by intra-vascular kidney administration of the recombinant vectors and pharmaceutical compositions of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.